The upregulation of NEAT1 in MS patients leads to an increase in the pro-inflammatory cytokine IL-8 through the modulation of splicing factor proline/glutamine-rich (SFPQ) [66]. The gene discussed is NEAT1; the disease is myeloid sarcoma.